Indication
Bleeding Risk
2 clinical trials
4 products
Product
OctaplexClinical trial
A Phase III, Randomized, Double-blind, Multicenter Study to Assess the Efficacy and Safety of OCTAPLEX, a Four-factor Prothrombin Complex Concentrate (4F-PCC), Compared to the 4F-PCC Beriplex® P/N (Kcentra), for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.Status: Completed, Estimated PCD: 2022-02-23
Product
Beriplex P/NClinical trial
Post Marketing Observational Study on Safety of BALFAXAR® vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure.Status: Not yet recruiting, Estimated PCD: 2031-12-31
Product
BalfaxarProduct
Kcentra